pe
pep-10332 v1 CC-BY-SA-4.0

Brain-signaling blocker for pain and dementia research (M35 peptide)

A lab-made peptide that blocks galanin, a brain-signaling chemical, to reduce nerve pain and seizure activity in animal studies; used only as a research tool.

statusbioassayed targetGALR1 length21 aa refs3
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 5 / 5
prediction metrics boltz-2 2.2.1
ipTM0.940
pTM0.897
avg pLDDT76.6
ranking score0.800
STRUCTURE · PEP-10332 × GALR1
ranking0.800
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 2.2.1 · mmCIF ↓ download
sequence21 aa
1510152021
GWTLNSA GYLLGPP PGFSPFR
details expand to inspect
full evidence table1 metrics
metricvaluetool
Ki 0.01 nM GPCRDB/ChEMBL
3-letter notation
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategycolabfold_local
runtime
predicted by
predicted at2026-05-22
citationbibtex
peptidemodel (2026). Brain-signaling blocker for pain and dementia research (M35 peptide) (pep-10332, v1). PeptideModel. https://peptidemodel.com/card/pep-10332
@peptide{pep10332,
  sequence = {GWTLNSAGYLLGPPPGFSPFR},
  target   = {galr1},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
clinical trials 0 trials · checked 2026-05-22
0
no registered clinical trials as of 2026-05-22; we'll re-check periodically
references 3 papers
[1]
Galanin receptors as a potential target for neurological disease
Freimann, K. et al. Expert Opinion on Therapeutic Targets 2015
evidence
[2]
Galanin Receptors and Ligands
Webling, K. et al. Frontiers in Endocrinology 2012
evidence
[3] supporting
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use